CLINICAL_TRIALS
trial_result
· 2009-06-19
Clinical Trial Update: CELLO - CLiRpath® Excimer Laser System to Enlarge Lumen Openings [Phase 3]
Summary
Phase 3 results for the CELLO CLiRpath Excimer Laser System to enlarge lumen openings in Peripheral Artery Disease have been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Spectranetics Corporation | Conditions: Peripheral Artery Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-06-19